The key new techniques in the medicinal chemist’s toolkit to prioritize solubility during drug design

Reference

• 1. Van de Waterbeemd H, Smith DA, Beaumont K, Walker DK. Property-based design: optimization of drug absorption and pharmacokinetics. J. Med. Chem. 44(9), 1313–1333 (2001).
  MedlineGoogle Scholar
• 2. Li D, Paul VF, Takashi M. Bridging solubility between drug discovery and development. Drug Discov.Today 17(9-10), 486–495 (2012).
  MedlineGoogle Scholar
• 3. Schneider G. Automating drug discovery. Nat Rev Drug Discov. 17, 97–113 (2018).
  Medline CASGoogle Scholar
• 4. Das B, Baidya ATK, Mathew A et al. Structural modification aimed for improving solubility of lead compounds in early phase drug discovery. Bioorg. Med. Chem. 56, 116614 (2022).
  Medline CASGoogle Scholar
• 5. Ishikawa M, Hashimoto Y. Improving the water-solubility of compounds by molecular modification to disrupt crystal packing. The Practice of Medicinal Chemistry (4th Edition). Wermuth CGAldous DRaboisson PRognan D (Eds.). Academic Press, London, UK, 747–765 (2015).
  Google Scholar
• 6. Charalabidis A, Sfouni M, Bergström C, Macheras P. The biopharmaceutics classification system (BCS) and the biopharmaceutics drug disposition classification system (BDDCS): beyond guidelines. Int. J. Pharm. 566, 264–281 (2019).
  Medline CASGoogle Scholar
• 7. Saal C, Petereit AC. Optimizing solubility: kinetic versus thermodynamic solubility temptations and risks. Eur. J. Pharm. Sci. 47, 589–595 (2012).
  Medline CASGoogle Scholar
• 8. Testa B, Crivori P, Reist M, Carrupt PA. The influence of lipophilicity on the pharmacokinetic behavior of drugs: Concepts and examples. Perspectives in Drug Discovery and Design 19(1), 179–211 (2000).
  Google Scholar
• 9. Naylor MR, Ly AM, Handford MJ et al. Lipophilic permeability efficiency (LPE) reconciles the opposing roles of lipophilicity in membrane permeability and aqueous solubility. J. Med. Chem. 61, 11169–11182 (2018).
  Medline CASGoogle Scholar
• 10. Lu Y, Li C-M, Wang Z. Design, synthesis, and SAR studies of 4-substituted methoxylbenzoyl-aryl-thiazoles analogues as potent and orally bioavailable anticancer agents. J. Med. Chem. 54, 4678–4693 (2011).
  Medline CASGoogle Scholar
• 11. Kuhn B, Mohr P, Stahl M. Intramolecular hydrogen bonding in medicinal chemistry. J. Med. Chem. 53, 2601–2611 (2010).
  Medline CASGoogle Scholar
• 12. Etter MC. Encoding and decoding hydrogen-bond patterns of organic compounds. Acc. Chem. Res. 23, 120–126 (1990).
  CASGoogle Scholar
• 13. Pinal R. Effect of molecular symmetry on melting temperature and solubility. Org. Biomol. Chem. 2, 2692–2699 (2004).
  Medline CASGoogle Scholar
• 14. Nikam SS, Cordon JJ, Ortwine DF et al. Design and synthesis of novel quinoxaline-2, 3-dione AMPA/GlyN receptor antagonists: amino acid derivatives. J. Med. Chem. 42, 2266–2271 (1999).
  Medline CASGoogle Scholar
• 15. Fujita Y, Yonehara M, Tetsuhashi M et al. β-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: Improvement of solubility by disruption of molecular planarity. Bioorg Med Chem. 18, 1194–1203 (2010).
  Medline CASGoogle Scholar
• 16. Bachovchin KA, Sharma A, Bag S et al. Improvement of aqueous solubility of lapatinib-derived analogues: identification of a quinolinimine lead for human African trypanosomiasis drug development. J. Med. Chem. 62, 665–687 (2018).
  Google Scholar
• 17. Lewin G, Maciuk A, Moncomble AI, Cornard J-P. Enhancement of the water solubility of flavone glycosides by disruption of molecular planarity of the aglycone moiety. J. Nat. Prod. 76, 8–12 (2013).
  Medline CASGoogle Scholar
• 18. Kumari S, Carmona AV, Tiwari AK, Trippier PC. Amide bond bioisosteres: strategies, synthesis, and successes. J. Med. Chem. 63, 12290–12358 (2020).
  Medline CASGoogle Scholar
• 19. Rubio-Ruiz B, Pérez-López AM, Sebastián V, Unciti-Broceta A. A minimally masked inactive prodrug of panobinostat that is bioorthogonally activated by gold chemistry. Bioorg. Med. Chem. 41, 116217–116223 (2021).
  Medline CASGoogle Scholar
• 20. Jornada DH, dos Santos Fernandes GF, Chiba DE et al. The prodrug approach: a successful tool for improving drug solubility. Molecules 21, 42–73 (2016).
  Google Scholar